Alkermes Ownership | Who Owns Alkermes?

Overview Forecast RevenueFinancials Chart Transcripts

Alkermes Ownership Summary

Alkermes is owned by 108.11% institutional investors, 1.32% insiders. Blackrock is the largest institutional shareholder, holding 17.33% of ALKS shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 6.58% of its assets in Alkermes shares.

ALKS Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Alkermes	108.11%	1.32%	-9.43%
Sector	Healthcare Stocks	49.73%	8.84%	41.43%
Industry	Biotech Stocks	47.04%	8.74%	44.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Blackrock	29.11M	17.33%	$701.49M
Vanguard group	20.00M	11.91%	$482.00M
Wellington management group llp	14.35M	8.55%	$345.95M
Price t rowe associates inc /md/	11.01M	6.56%	$265.40M
State street	9.22M	5.49%	$222.08M
Rtw investments, lp	7.06M	4.20%	$170.07M
Pacer advisors	5.64M	3.36%	$135.94M
Renaissance	5.48M	3.26%	$132.16M
Baker bros. advisors lp	4.18M	2.49%	$100.78M
Geode capital management	3.93M	2.34%	$94.83M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Krensavage asset management	257.55K	2.85%	$6.21M
Rtw investments, lp	7.06M	2.63%	$170.07M
Deep track capital, lp	3.50M	2.52%	$84.35M
Commodore capital lp	1.38M	2.26%	$33.14M
Affinity asset advisors	650.00K	1.81%	$15.66M
Sector gamma as	194.00K	1.75%	$4.68M
Palo alto investors lp	495.59K	1.38%	$11.94M
Baker bros. advisors lp	4.18M	1.29%	$100.78M
Birchview capital, lp	50.00K	1.12%	$1.21M
Healthinvest partners ab	68.80K	1.01%	$1.66M

Top Buyers

Holder	Shares	% Assets	Change
Baker bros. advisors lp	4.18M	1.29%	4.18M
Price t rowe associates inc /md/	11.01M	0.03%	2.69M
Norges bank	2.13M	0.01%	2.13M
Armistice capital	2.70M	0.82%	2.03M
Commodore capital lp	1.38M	2.26%	1.38M

Top Sellers

Holder	Shares	% Assets	Change
Hardman johnston global advisors	-	-	-2.67M
Pictet asset management sa	1.03M	0.03%	-1.70M
Westfield capital management co lp	-	-	-1.32M
Jacobs levy equity management	-	-	-1.25M
Jupiter asset management	-	-	-1.02M

New Positions

Holder	Shares	% Assets	Change	Value
Baker bros. advisors lp	4.18M	1.29%	4.18M	$100.78M
Norges bank	2.13M	0.01%	2.13M	$51.31M
Commodore capital lp	1.38M	2.26%	1.38M	$33.14M
Schroder investment management group	248.39K	0.01%	248.39K	$5.99M
Exoduspoint capital management, lp	170.65K	0.03%	170.65K	$4.11M

Sold Out

Holder	Change
Financial gravity asset management	-1.00
Harbor investment advisory	-1.00
Mather group, llc.	-2.00
Financial synergies wealth advisors	-9.00
Bogart wealth	-19.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2024	339	3.99%	176,619,359	-1.51%	108	0.95%	171	-2.29%	117	7.34%
Jun 30, 2024	320	-6.16%	179,232,053	3.05%	106	0.97%	172	-	109	-9.17%
Mar 31, 2024	341	10.36%	173,933,414	-0.77%	104	0.95%	172	-3.91%	120	42.86%
Dec 31, 2023	309	-3.74%	175,286,825	8.10%	105	1.10%	179	-5.79%	84	6.33%
Sep 30, 2023	321	7.36%	162,149,196	0.93%	97	1.03%	190	22.58%	79	-10.23%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
iShares Core S&P Small-Cap ETF	10.65M	6.58%	4.78K
Vanguard Health Care Inv	8.60M	5.32%	-
T. Rowe Price Mid-Cap Value	5.62M	3.42%	139.99K
T. Rowe Price US Mid-Cap Value Equity	5.62M	3.42%	1.05M
Vanguard Total Stock Mkt Idx Inv	5.13M	3.17%	-23.54K
iShares Russell 2000 ETF	4.54M	2.81%	-9.49K
Vanguard Small Cap Index	4.13M	2.55%	8.10K
Pacer US Small Cap Cash Cows 100 ETF	4.05M	2.50%	-2.12K
T. Rowe Price U.S. Mid-Cap Val Eq Tr-Z	2.97M	1.80%	561.42K
SPDR® S&P Biotech ETF	2.80M	1.73%	-84.96K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Dec 09, 2024	Hopkinson Craig C.	EVP R&D, Chief Medical Officer	Sell	$1.96M
Dec 09, 2024	LAURENCIN CATO T	-	Sell	$85.71K
Dec 05, 2024	Hopkinson Craig C.	EVP R&D, Chief Medical Officer	Sell	$290.46K
Dec 04, 2024	Hopkinson Craig C.	EVP R&D, Chief Medical Officer	Sell	$441.55K
Nov 27, 2024	Nichols Christian Todd	SVP, Chief Commercial Officer	Sell	$151.81K

Insider Transactions Trends

Date	Buy	Sell
2024 Q4	-	7
2024 Q3	-	-
2024 Q2	-	-
2024 Q1	-	3
2023 Q4	-	-

ALKS Ownership FAQ

Who Owns Alkermes?

Alkermes shareholders are primarily institutional investors at 108.11%, followed by 1.32% insiders and -9.43% retail investors. The average institutional ownership in Alkermes's industry, Biotech Stocks , is 47.04%, which Alkermes exceeds.

Who owns the most shares of Alkermes?

Alkermes’s largest shareholders are Blackrock (29.11M shares, 17.33%), Vanguard group (20M shares, 11.91%), and Wellington management group llp (14.35M shares, 8.55%). Together, they hold 37.78% of Alkermes’s total shares outstanding.

Does Blackrock own Alkermes?

Yes, BlackRock owns 17.33% of Alkermes, totaling 29.11M shares as of Jun 2024. This represents 0.02% of BlackRock's total assets, with a market value of 701.49M$. In the last quarter, BlackRock decreased its holdings by -60.933K shares, a -0.21% change.

Who is Alkermes’s biggest shareholder by percentage of total assets invested?

Krensavage asset management is Alkermes’s biggest shareholder by percentage of total assets invested, with 2.85% of its assets in 257.55K Alkermes shares, valued at 6.21M$.

Who is the top mutual fund holder of Alkermes shares?

iShares Core S&P Small-Cap ETF is the top mutual fund holder of Alkermes shares, with 6.58% of its total shares outstanding invested in 10.65M Alkermes shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools